The NADITEMM project
The goal of the project is the creation of innovative systems for the early diagnosis of metabolic disorders and nutraceutical products useful for their correction in the earliest stages of the disease, with a view to reducing the medicalization of the population and optimizing prescriptive appropriateness. A second specific objective of the project is the development of an innovative device that allows the obese subject and / or the subject with diabetes mellitus 2, the early identification of any peripheral alterations attributable to automatic neuropathy that make it possible to diagnose the onset of this complication early.
Project partners:
- Biotecnomed S.c.a r.l.
- Consortium PITECNOBIO S.c.a.r.l.
- BIONAP S.r.l.
- Magna Graecia University of Catanzaro
Funds: PON 2014-2020
Total investment: € 7.042.997,00
Total contribution: € 3.412.928,50
Period: 2018-2021
